[go: up one dir, main page]

FI892640L - Menetelmä piperidinoalkanoli-ibuprofeeniyhdistelmää sisältävän farmaseuttisen koostumuksen valmistamiseksi - Google Patents

Menetelmä piperidinoalkanoli-ibuprofeeniyhdistelmää sisältävän farmaseuttisen koostumuksen valmistamiseksi Download PDF

Info

Publication number
FI892640L
FI892640L FI892640A FI892640A FI892640L FI 892640 L FI892640 L FI 892640L FI 892640 A FI892640 A FI 892640A FI 892640 A FI892640 A FI 892640A FI 892640 L FI892640 L FI 892640L
Authority
FI
Finland
Prior art keywords
piperidinoalkanol
preparing
pharmaceutical composition
composition containing
ibuprofen combination
Prior art date
Application number
FI892640A
Other languages
English (en)
Swedish (sv)
Other versions
FI90205C (fi
FI90205B (fi
FI892640A0 (fi
Inventor
Herbert Schock
David Francis Long
William Richard Nadler
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of FI892640A0 publication Critical patent/FI892640A0/fi
Publication of FI892640L publication Critical patent/FI892640L/fi
Application granted granted Critical
Publication of FI90205B publication Critical patent/FI90205B/fi
Publication of FI90205C publication Critical patent/FI90205C/fi

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI892640A 1988-06-01 1989-05-31 Menetelmä piperidinoalkanoli-ibuprofeeniyhdistelmää sisältävän farmaseuttisen koostumuksen valmistamiseksi FI90205C (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US20081788A 1988-06-01 1988-06-01
US20081788 1988-06-01
US34418389 1989-04-27
US07/344,183 US4999226A (en) 1988-06-01 1989-04-27 Pharmaceutical compositions for piperidinoalkanol-ibuprofen combination

Publications (4)

Publication Number Publication Date
FI892640A0 FI892640A0 (fi) 1989-05-31
FI892640L true FI892640L (fi) 1989-12-02
FI90205B FI90205B (fi) 1993-09-30
FI90205C FI90205C (fi) 1994-01-10

Family

ID=26896133

Family Applications (1)

Application Number Title Priority Date Filing Date
FI892640A FI90205C (fi) 1988-06-01 1989-05-31 Menetelmä piperidinoalkanoli-ibuprofeeniyhdistelmää sisältävän farmaseuttisen koostumuksen valmistamiseksi

Country Status (17)

Country Link
US (1) US4999226A (fi)
EP (1) EP0348683B1 (fi)
JP (1) JP2757017B2 (fi)
KR (1) KR0126129B1 (fi)
CN (1) CN1038021A (fi)
AU (1) AU615751B2 (fi)
CA (1) CA1327011C (fi)
DE (1) DE68900378D1 (fi)
DK (1) DK174638B1 (fi)
ES (1) ES2037908T3 (fi)
FI (1) FI90205C (fi)
GR (1) GR3003477T3 (fi)
HU (1) HU202746B (fi)
IE (1) IE61182B1 (fi)
IL (1) IL90461A0 (fi)
NZ (1) NZ229325A (fi)
PT (1) PT90689B (fi)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5605930A (en) * 1991-10-21 1997-02-25 The United States Of America As Represented By The Department Of Health And Human Services Compositions and methods for treating and preventing pathologies including cancer
JPH069382A (ja) * 1992-04-17 1994-01-18 Takeda Chem Ind Ltd 安定化された固型製剤およびその製造方法
JPH08506808A (ja) * 1992-12-21 1996-07-23 ザ、プロクター、エンド、ギャンブル、カンパニー 呼吸障害治療用組成物の製造における鎮痛剤s(+)対掌体の利用
EP0707475B1 (en) * 1993-06-14 1997-09-17 Janssen Pharmaceutica N.V. Extended release, film-coated tablet of astemizole and pseudoephedrine
CN1060040C (zh) * 1993-10-25 2001-01-03 默里尔药物公司 稳定的丁苯哌丁醇与布洛芬的药物组合物
DK0812589T3 (da) * 1993-12-10 2000-11-13 Fujisawa Pharmaceutical Co Kombineret antipyretisk og analgetisk lægemiddel
US5419917A (en) * 1994-02-14 1995-05-30 Andrx Pharmaceuticals, Inc. Controlled release hydrogel formulation
US5399356A (en) * 1994-03-24 1995-03-21 The Procter & Gamble Company Process for making solid dose forms containing bismuth
KR100405116B1 (ko) * 1995-02-28 2004-02-05 아벤티스 파마슈티칼스 인크. 피페리디노알칸올화합물에대한약제학적조성물
US5574045A (en) * 1995-06-06 1996-11-12 Hoechst Marion Roussel, Inc. Oral pharmaceutical composition of piperidinoalkanol compounds in solution form
US6077539A (en) * 1996-11-12 2000-06-20 Pozen, Inc. Treatment of migraine headache
PT998272E (pt) * 1997-08-26 2003-09-30 Aventis Pharma Inc Composicao farmaceutica para combinacao do descongestionante piperidinoalcanol
AR030920A1 (es) * 1999-11-16 2003-09-03 Smithkline Beecham Plc Composiciones farmaceuticas para el tratamiento de la diabetes mellitus y condiciones asociadas con la diabetes mellitus, y procedimientos para preparar dichas composiciones
WO2002036077A2 (en) * 2000-11-06 2002-05-10 Andrx Pharmaceuticals, Inc. Once a day antihistamine and decongestant formulation
US20040018239A1 (en) * 2000-11-17 2004-01-29 Hajime Ishida Pharmaceutical preparation containing copolyvidone
CA2461653A1 (en) * 2001-09-28 2003-04-03 Mcneil-Ppc, Inc. Edible composition and dosage form comprising an edible shell
US20030181488A1 (en) 2002-03-07 2003-09-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Administration form for the oral application of 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethyl ester and the salts thereof
US7807197B2 (en) * 2002-09-28 2010-10-05 Mcneil-Ppc, Inc. Composite dosage forms having an inlaid portion
US8092831B2 (en) * 2002-11-08 2012-01-10 Andrx Pharmaceuticals, Llc Antihistamine and decongestant system
US20040253311A1 (en) * 2002-12-18 2004-12-16 Roger Berlin Multi-layer tablet comprising non-steroidal anti-inflammatory drugs, decongestants and non-sedating antihist amines
US20050220877A1 (en) * 2004-03-31 2005-10-06 Patel Ashish A Bilayer tablet comprising an antihistamine and a decongestant
CN1960713A (zh) * 2004-05-21 2007-05-09 阿库-伯雷克技术公司 含有两个或多个单元片段的药片
AU2005245026B2 (en) * 2004-05-21 2010-07-01 Accu-Break Technologies, Inc. Immediate release pharmaceutical tablets with height greater than width
US8673352B2 (en) * 2005-04-15 2014-03-18 Mcneil-Ppc, Inc. Modified release dosage form
CA2635313C (en) 2005-12-29 2013-12-31 Osmotica Corp. Triple combination release multi-layered tablet
CA2750196C (en) * 2009-01-05 2017-06-20 Mcneil-Ppc, Inc. Tablet containing coated particles of cetirizine, pseudoephedrine, and/or naproxen
US8377475B2 (en) 2009-01-05 2013-02-19 Mcneil-Ppc, Inc. Tablet containing cetirizine, pseudoephedrine, and naproxen containing a barrier layer
US8246988B2 (en) 2009-01-05 2012-08-21 Mcneil-Ppc, Inc. Three layer tablet containing cetirizine, pseudoephedrine, and naproxen
US20130115250A1 (en) * 2009-05-13 2013-05-09 Wyeth Llc Burst Drug Release Compositions
MX392727B (es) 2016-12-09 2025-03-24 Bayer Animal Health Gmbh Preparación framaceútica de estructura multicapa y método para su fabricación
CN108703828B (zh) * 2018-06-04 2021-03-30 王荣涛 下肢牵引器
CN109481272B (zh) * 2019-01-10 2020-07-24 河南省洛阳正骨医院(河南省骨科医院) 肺癌骨转移术后康复装置

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL70071A (en) * 1982-11-01 1987-12-31 Merrell Dow Pharma Multilayered sustained release pharmaceutical tablets having non-uniform distribution of active ingredient
US4882167A (en) * 1983-05-31 1989-11-21 Jang Choong Gook Dry direct compression compositions for controlled release dosage forms
US4783465A (en) * 1984-04-09 1988-11-08 Analgesic Associates Cough/cold mixtures comprising non-sedating antihistamine drugs
US4552899A (en) * 1984-04-09 1985-11-12 Analgesic Associates Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs
US4806359A (en) * 1987-04-22 1989-02-21 Mcneilab, Inc. Iburprofen sustained release matrix and process
US4808413A (en) * 1987-04-28 1989-02-28 E. R. Squibb & Sons, Inc. Pharmaceutical compositions in the form of beadlets and method

Also Published As

Publication number Publication date
DE68900378D1 (de) 1991-12-05
FI90205C (fi) 1994-01-10
HU202746B (en) 1991-04-29
DK265489A (da) 1989-12-02
PT90689A (pt) 1989-12-29
EP0348683A1 (en) 1990-01-03
FI90205B (fi) 1993-09-30
IE61182B1 (en) 1994-10-05
US4999226A (en) 1991-03-12
GR3003477T3 (en) 1993-02-17
KR900017573A (ko) 1990-12-19
FI892640A0 (fi) 1989-05-31
PT90689B (pt) 1993-12-31
ES2037908T3 (es) 1993-07-01
IE891795L (en) 1989-12-01
IL90461A0 (en) 1990-01-18
CN1038021A (zh) 1989-12-20
NZ229325A (en) 1990-10-26
HUT52367A (en) 1990-07-28
KR0126129B1 (ko) 1997-12-24
DK265489D0 (da) 1989-05-31
CA1327011C (en) 1994-02-15
AU615751B2 (en) 1991-10-10
EP0348683B1 (en) 1991-10-30
JP2757017B2 (ja) 1998-05-25
AU3580089A (en) 1989-12-07
JPH0228111A (ja) 1990-01-30
DK174638B1 (da) 2003-08-04

Similar Documents

Publication Publication Date Title
FI892640L (fi) Menetelmä piperidinoalkanoli-ibuprofeeniyhdistelmää sisältävän farmaseuttisen koostumuksen valmistamiseksi
FI894342L (fi) Menetelmä syklosporiinia sisältävän farmaseuttisen koostumuksen valmistamiseksi
FI906249A7 (fi) Menetelmä farmaseuttisen seoksen valmistamiseksi
FI881978L (fi) Menetelmä eperisonia sisältävän farmaseuttisen koostumuksen valmistamiseksi
FI914398A7 (fi) Menetelmä farmaseuttisen kokoonpanon valmistamiseksi
FI885884L (fi) Menetelmä hitaasti vapautuvan farmaseuttisen koostumuksen valmistamiseksi
FI893520L (fi) Menetelmä intravenoosisen farmaseuttisen koostumuksen valmistamiseksi
FI871951L (fi) Menetelmä kiinteän lääkevalmisteen valmistamiseksi
FI891570L (fi) Menetelmä piroksikaamia sisältävän farmaseuttisen koostumuksen valmistamiseksi
FI894637L (fi) Menetelmä mikroemulsion käsittävän farmaseuttisen formulaation valmistamiseksi
FI883261L (fi) Menetelmä somatostatiinia sisältävän farmaseuttisen ainekoostumuksen valmistamiseksi
FI891711L (fi) Menetelmä diorganodialkoksisilaanien valmistamiseksi
FI895766A7 (fi) Menetelmä uusien lysosfingolipidien valmistamiseksi
ZA895838B (en) Pharmaceutical compounds
FI20001776L (fi) Menetelmä farmaseuttisen koostumuksen valmistamiseksi
FI884240L (fi) Menetelmä paikalliseen käyttöön tarkoitetun farmaseuttisen valmisteen valmistamiseksi
FI891677L (fi) Menetelmä 4-demetoksidaunomysinonin valmistamiseksi
PH25102A (en) Pharmaceutical compounds
FI913554L (fi) Menetelmä stabiloidun farmaseuttisen koostumuksen valmistamiseksi
FI873407L (fi) Menetelmä pitkävaikutteisen moniraetabletin valmistamiseksi
FI912868A7 (fi) Menetelmä farmaseuttisten yhdisteiden valmistamiseksi
FI891362A7 (fi) Menetelmä uusien alkanofenonien valmistamiseksi
FI895800A7 (fi) Menetelmä uusien a-syano-b-oksopropioniamidien valmistamiseksi
PT87672A (pt) Process for preparing a pharmaceutical composition
FI870050A0 (fi) Menetelmä hajunpoistoaineen valmistamiseksi

Legal Events

Date Code Title Description
BB Publication of examined application
FG Patent granted

Owner name: MERRELL DOW PHARMACEUTICALS INC.

PC Transfer of assignment of patent

Owner name: AVENTIS INC.

Free format text: AVENTIS INC.

MA Patent expired